<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 38-year-old woman with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and the <z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibody syndrome was admitted because of rapidly evolving symptoms consistent with a transverse <z:hpo ids='HP_0002196'>myelopathy</z:hpo> at the TH9/10 level </plain></SENT>
<SENT sid="1" pm="."><plain>Magnetic resonance imaging (MRI) showed slight diffuse swelling and increased signal intensity of the spinal cord </plain></SENT>
<SENT sid="2" pm="."><plain>She was treated with high dose <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> plus <z:chebi fb="2" ids="2948">azathioprine</z:chebi> and aspirin </plain></SENT>
<SENT sid="3" pm="."><plain>Four months later she had achieved almost complete remission with minimal residual <z:hpo ids='HP_0002839'>sphincter disturbances</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Despite the clinical recovery, repeated MRI at 4 months and 4 years showed diffuse and irreversible <z:mpath ids='MPATH_127'>atrophy</z:mpath> of the entire spinal cord </plain></SENT>
</text></document>